Skip to main content
NIH funding notice PA-18-784

The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed)

Closed on September 7, 2021.

Posted
May 14, 2018
Close date
September 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

20 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,590,272 in first-year total cost, median $565,054.

Most frequent study sections

  1. Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]4
  2. Atherosclerosis and Inflammation of the Cardiovascular System Study Section[AICS]3
  3. Hypertension and Microcirculation Study Section[HM]2
  4. Lung Injury, Repair, and Remodeling Study Section[LIRR]2
  5. Cancer, Heart, and Sleep Epidemiology B Study Section[CHSB]1

Most frequent institutions

  1. UNIVERSITY OF MICHIGAN AT ANN ARBOR3
  2. UNIVERSITY OF CALIFORNIA, SAN DIEGO2
  3. CALIFORNIA INSTITUTE OF TECHNOLOGY1
  4. CLEVELAND CLINIC LERNER COM-CWRU1
  5. LOYOLA UNIVERSITY CHICAGO1
Competing awards under PA-18-784 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Relationship of fungal translocation, inflammation, and pulmonary function in HIV1R01HL164177-01METHE, BARBARAMORRIS, ALISONUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$786,162HCCS
2022Obstructive sleep apnea, the microbiome and cardiovascular disease1R01HL157445-01A1HADDAD, GABRIEL GUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$726,129RIBT
2022Gut Microbiota and Host Regulatory Cross-Talk in Pulmonary Fibrosis1R01HL162659-01O'DWYER, DAVID NOELUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$510,906LIRR
2021Gut Microbiota and Host Regulatory Cross-Talk in Pulmonary Fibrosis1R56HL155055-01A1O'DWYER, DAVID NOELUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$477,040LIRR
2021Neural mechanisms of host-microbiota interaction in hypertension: a potential for bio-electronic medicine1R01HL152162-01A1ZUBCEVIC, JASENKAUNIVERSITY OF TOLEDO HEALTH SCI CAMPUS, OH$465,342HM
2021Microbiota Regulation of Pulmonary Complications Post-HCT1R01HL153028-01A1ZHOU, XIAOFENGUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$381,600LCMI
2020Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis1R01HL148815-01A1GHADIRI, M. REZASCRIPPS RESEARCH INSTITUTE, THE, CA$734,089SBCB
2020Establishing mechanistic links between the gut microbiome and atherosclerosis1R01HL148577-01A1LUSIS, ALDONS JAKEREY, FEDERICO EUNIVERSITY OF WISCONSIN-MADISON, WI$659,659AICS
2020Role of the Gut Microbiota in Abdominal Aortic Aneurysm1R01HL147171-01A1OWENS III, ALBERT PHILLIPUNIVERSITY OF CINCINNATI, OH$658,280AICS
2020Gut Dysbiosis and Cardiac Remodeling in IBD1R01HL152683-01A1FUJISE, KENLI, QINGJIEUNIVERSITY OF TEXAS MED BR GALVESTON, TX$653,505CCHF
2020Gut Microbiota and Cerebral Vascular Disease1R01HL150537-01A1ZHU, WEIFEICLEVELAND CLINIC LERNER COM-CWRU, OH$551,373HM
2020The Gut-Lung Axis: Immunometabolism Linking the Gut Microbiome and Lung Imunity1R01HL146753-01A1PRAKASH BUDDE, ARUNUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$534,037LCMI
2020Testing the hypothesis that microbial energetic hijacking of the CF immune response selects for specific pathogens during lung function decline1R01HL152190-01NEWMAN, DIANNE KCALIFORNIA INSTITUTE OF TECHNOLOGY, CA$490,423LCMI
2020Microbiota Control Lung Th17 Cell Response and Plasticity Leading to Autoimmune Lung Disease1R01HL148347-01A1WU, HSIN-JUNG JOYCEUNIVERSITY OF ARIZONA, AZ$444,243ZRG1
2020Host microbiota and airway mucus: a novel paradigm for lung defense and immune homeostasis during early post-natal development1R01HL150541-01LIVRAGHI-BUTRICO, ALESSANDRA MARIAUNIV OF NORTH CAROLINA CHAPEL HILL, NC$383,200LCMI
2020Novel mechanism in microbiota-brain communication: the role of the hepatoportal region1R01HL151853-01KAPAS, LEVENTESZENTIRMAI, EVAWASHINGTON STATE UNIVERSITY, WA$382,500NNRS
2019METS-Sleep: Sleep timing, gut microbiota and cardiometabolic risk across the Epidemiologic Transition1R01HL148271-01DUGAS, LARA RUTHLAYDEN, BRIAN THOMASLOYOLA UNIVERSITY CHICAGO, IL$798,387CHSB
2019The Role of Altered Luminal Dynamics in OSA-Induced Atherosclerosis1R01HL148801-01ZARRINPAR, AMIRUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$701,686AICS
2019Helicobacter pylori infection and endothelial dysfunction1R01HL148196-01LIU, ZHENGUOUNIVERSITY OF MISSOURI-COLUMBIA, MO$672,977VCMB
2019Immunological and functional consequences triggered by the gut microbiota regulate alloimmunity and cardiac transplant outcome1R01HL148672-01BROMBERG, JONATHAN SMONGODIN, EMMANUELUNIVERSITY OF MARYLAND BALTIMORE, MD$578,734TTT

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-784: The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed) | ScienceDex | ConductScience